Preserved dendritic cell HLA-DR expression and reduced regulatory T cell activation in Asymptomatic Plasmodium falciparum and P. vivax infection

Infection and Immunity

Volumn 83, Issue 8, 2015, Pages 3224-3232

  Kho, Steven ^a   Marfurt, Jutta ^a   Noviyanti, Rintis ^b   Kusuma, Andreas ^b   Piera, Kim A ^a   Burdam, Faustina H ^c   Kenangalem, Enny ^c,d   Lampah, Daniel A ^c   Engwerda, Christian R ^e   Poespoprodjo, Jeanne R ^c,d,f   Price, Ric N ^a,g   Anstey, Nicholas M ^a   Minigo, Gabriela ^a   Woodberry, Tonia ^a  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b EIJKMAN INSTITUTE FOR MOLECULAR BIOLOGY   (Indonesia)

^c Papuan Health and Community Development Foundation   (Indonesia)

^d Rumah Sakit Umum Daerah Kabupaten Mimika ^*  (Indonesia)

^e QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^f GADJAH MADA UNIVERSITY   (Indonesia)

^g UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN;

ADOLESCENT; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CHILD; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; INDONESIA; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; NONHUMAN; PAPUA NEW GUINEA; PARASITEMIA; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ADULT; ASYMPTOMATIC DISEASE; CROSS-SECTIONAL STUDY; DOWN REGULATION; FEMALE; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALARIA, FALCIPARUM; MALARIA, VIVAX; MALE; PARASITOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; ASYMPTOMATIC DISEASES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DENDRITIC CELLS; DOWN-REGULATION; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; INDONESIA; LYMPHOCYTE ACTIVATION; MALARIA, FALCIPARUM; MALARIA, VIVAX; MALE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 84937793021     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00226-15     Document Type: Article

References (49)

1. WHO. 2013. World malaria report 2013. World Health Organization, Geneva, Switzerland. http://www.who.int/malaria/publications/world_malaria_report_2013.
2. Anstey NM, Douglas NM, Poespoprodjo JR, Price RN. 2012. Plasmodium vivax: clinical spectrum, risk factors and pathogenesis. Adv Parasitol 80:151-201. http://dx.doi.org/10.1016/B978-0-12-397900-1.00003-7.
3. Karyana M, Burdarm L, Yeung S, Kenangalem E, Wariker N, Maristela R, Umana KG, Vemuri R, Okoseray MJ, Penttinen PM, Ebsworth P, Sugiarto P, Anstey NM, Tjitra E, Price RN. 2008. Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum. Malar J 7:148. http://dx.doi.org/10.1186/1475-2875-7-148.
4. Michon P, Cole-Tobian JL, Dabod E, Schoepflin S, Igu J, Susapu M, Tarongka N, Zimmerman PA, Reeder JC, Beeson JG, Schofield L, King CL, Mueller I. 2007. The risk of malarial infections and disease in Papua New Guinean children. Am J Trop Med Hyg 76:997-1008.
5. Smith T, Schellenberg JA, Hayes R. 1994. Attributable fraction estimates and case definitions for malaria in endemic areas. Stat Med 13:2345-2358. http://dx.doi.org/10.1002/sim.4780132206.
6. Alves FP, Gil LH, Marrelli MT, Ribolla PE, Camargo EP, Da Silva LH. 2005. Asymptomatic carriers of Plasmodium spp. as infection source for malaria vector mosquitoes in the Brazilian Amazon. J Med Entomol 42:777-779. http://dx.doi.org/10.1093/jmedent/42.5.777.
7. Bousema JT, Gouagna LC, Drakeley CJ, Meutstege AM, Okech BA, Akim IN, Beier JC, Githure JI, Sauerwein RW. 2004. Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya. Malar J 3:18. http://dx.doi.org/10.1186/1475-2875-3-18.
8. Pinzon-Charry A, Woodberry T, Kienzle V, McPhun V, Minigo G, Lampah DA, Kenangalem E, Engwerda C, Lopez JA, Anstey NM, Good MF. 2013. Apoptosis and dysfunction of blood dendritic cells in patients with falciparum and vivax malaria. J Exp Med 210:1635-1646. http://dx.doi.org/10.1084/jem.20121972.
9. Woodberry T, Minigo G, Piera KA, Amante FH, Pinzon-Charry A, Good MF, Lopez JA, Engwerda CR, McCarthy JS, Anstey NM. 2012. Low-level Plasmodium falciparum blood-stage infection causes dendritic cell apoptosis and dysfunction in healthy volunteers. J Infect Dis 206:333-340. http://dx.doi.org/10.1093/infdis/jis366.
10. Urban BC, Mwangi T, Ross A, Kinyanjui S, Mosobo M, Kai O, Lowe B, Marsh K, Roberts DJ. 2001. Peripheral blood dendritic cells in children with acute Plasmodium falciparum malaria. Blood 98:2859-2861. http://dx.doi.org/10.1182/blood.V98.9.2859.
11. Walther M, Tongren JE, Andrews L, Korbel D, King E, Fletcher H, Andersen RF, Bejon P, Thompson F, Dunachie SJ, Edele F, de Souza JB, Sinden RE, Gilbert SC, Riley EM, Hill AV. 2005. Upregulation of TGF-beta, FOXP3, and CD4+ CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity 23:287-296. http://dx.doi.org/10.1016/j.immuni.2005.08.006.
12. Minigo G, Woodberry T, Piera KA, Salwati E, Tjitra E, Kenangalem E, Price RN, Engwerda CR, Anstey NM, Plebanski M. 2009. Parasitedependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria. PLoS Pathog 5:e1000402.
13. Zander RA, Butler NS. 2013. Dysfunctional adaptive immunity during parasitic infections. Curr Immunol Rev 9:179-189.
14. Doolan DL, Dobano C, Baird JK. 2009. Acquired immunity to malaria. Clin Microbiol Rev 22:13-36. http://dx.doi.org/10.1128/CMR.00025-08.
15. Boutlis CS, Yeo TW, Anstey NM. 2006. Malaria tolerance-for whom the cell tolls? Trends Parasitol 22:371-377. http://dx.doi.org/10.1016/j.pt.2006.06.002.
16. Gupta S, Hill AV, Kwiatkowski D, Greenwood AM, Greenwood BM, Day KP. 1994. Parasite virulence and disease patterns in Plasmodium falciparum malaria. Proc Natl Acad Sci U S A 91:3715-3719. http://dx.doi.org/10.1073/pnas.91.9.3715.
17. Guinovart C, Dobano C, Bassat Q, Nhabomba A, Quinto L, Manaca MN, Aguilar R, Rodriguez MH, Barbosa A, Aponte JJ, Mayor AG, Renom M, Moraleda C, Roberts DJ, Schwarzer E, Le Souef PN, Schofield L, Chitnis CE, Doolan DL, Alonso PL. 2012. The role of age and exposure to Plasmodium falciparum in the rate of acquisition of naturally acquired immunity: a randomized controlled trial. PLoS One 7:e32362.
18. Fowkes FJ, Richards JS, Simpson JA, Beeson JG. 2010. The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: a systematic review and meta-analysis. PLoS Med 7:e1000218.
19. King CL, Michon P, Shakri AR, Marcotty A, Stanisic D, Zimmerman PA, Cole-Tobian JL, Mueller I, Chitnis CE. 2008. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. Proc Natl Acad Sci U S A 105:8363-8368. http://dx.doi.org/10.1073/pnas.0800371105.
20. Versiani FG, Almeida ME, Melo GC, Versiani FO, Orlandi PP, Mariuba LA, Soares LA, Souza LP, da Silva Balieiro AA, Monteiro WM, Costa FT, del Portillo HA, Lacerda MV, Nogueira PA. 2013. High levels of IgG3 anti ICB2-5 in Plasmodium vivax-infected individuals who did not develop symptoms. Malar J 12:294. http://dx.doi.org/10.1186/1475-2875-12-294.
21. Moormann AM, Sumba PO, Chelimo K, Fang H, Tisch DJ, Dent AE, John CC, Long CA, Vulule J, Kazura JW. 2013. Humoral and cellular immunity to Plasmodium falciparum merozoite surface protein 1 and protection from infection with blood-stage parasites. J Infect Dis 208:149-158. http://dx.doi.org/10.1093/infdis/jit134.
22. Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJ, van Gemert GJ, van de Vegte-Bolmer M, van Schaijk B, Teelen K, Arens T, Spaarman L, de Mast Q, Roeffen W, Snounou G, Renia L, van der Ven A, Hermsen CC, Sauerwein R. 2009. Protection against a malaria challenge by sporozoite inoculation. N Engl J Med 361:468-477. http://dx.doi.org/10.1056/NEJMoa0805832.
23. Bejon P, Mwacharo J, Kai O, Todryk S, Keating S, Lowe B, Lang T, Mwangi TW, Gilbert SC, Peshu N, Marsh K, Hill AV. 2007. The induction and persistence of T cell IFN-gamma responses after vaccina- tion or natural exposure is suppressed by Plasmodium falciparum. J Immunol 179:4193-4201. http://dx.doi.org/10.4049/jimmunol.179.6.4193.
24. McCall MB, Sauerwein RW. 2010. Interferon-gamma-central mediator of protective immune responses against the pre-erythrocytic and blood stage of malaria. J Leukoc Biol 88:1131-1143. http://dx.doi.org/10.1189/jlb.0310137.
25. Banchereau J, Steinman RM. 1998. Dendritic cells and the control of immunity. Nature 392:245-252. http://dx.doi.org/10.1038/32588.
26. Sakaguchi S, Vignali DA, Rudensky AY, Niec RE, Waldmann H. 2013. The plasticity and stability of regulatory T cells. Nat Rev Immunol 13:461-467. http://dx.doi.org/10.1038/nri3464.
27. Hardy MY, Vari F, Rossetti T, Hart DN, Prue RL. 2013. A flow cytometry based assay for the enumeration of regulatory T cells in whole blood. J Immunol Methods 390:121-126. http://dx.doi.org/10.1016/j.jim.2012.07.004.
28. Miyara M, Wing K, Sakaguchi S. 2009. Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion. J Allergy Clin Immunol 123:749-755. http://dx.doi.org/10.1016/j.jaci.2009.03.001.
29. Jangpatarapongsa K, Chootong P, Sattabongkot J, Chotivanich K, Sirichaisinthop J, Tungpradabkul S, Hisaeda H, Troye-Blomberg M, Cui L, Udomsangpetch R. 2008. Plasmodium vivax parasites alter the balance of myeloid and plasmacytoid dendritic cells and the induction of regulatory T cells. Eur J Immunol 38:2697-2705. http://dx.doi.org/10.1002/eji.200838186.
30. Bueno LL, Morais CG, Araujo FF, Gomes JA, Correa-Oliveira R, Soares IS, Lacerda MV, Fujiwara RT, Braga EM. 2010. Plasmodium vivax:induction of CD4+CD25+FoxP3+ regulatory T cells during infection are directly associated with level of circulating parasites. PLoS One 5:e9623.
31. Bruce MC, Donnelly CA, Alpers MP, Galinski MR, Barnwell JW, Walliker D, Day KP. 2000. Cross-species interactions between malaria parasites in humans. Science 287:845- 848. http://dx.doi.org/10.1126/science.287.5454.845.
32. McCarthy JS, Sekuloski S, Griffin PM, Elliott S, Douglas N, Peatey C, Rockett R, O'Rourke P, Marquart L, Hermsen C, Duparc S, Mohrle J, Trenholme KR, Humberstone AJ. 2011. A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs. PLoS One 6:e21914.
33. Engwerda CR, Minigo G, Amante FH, McCarthy JS. 2012. Experimentally induced blood stage malaria infection as a tool for clinical research. Trends Parasitol 28:515-521. http://dx.doi.org/10.1016/j.pt.2012.09.001.
34. Arama C, Giusti P, Bostrom S, Dara V, Traore B, Dolo A, Doumbo O, Varani S, Troye-Blomberg M. 2011. Interethnic differences in antigenpresenting cell activation and TLR responses in Malian children during Plasmodium falciparum malaria. PLoS One 6:e18319.
35. Lisse IM, Aaby P, Whittle H, Knudsen K. 1994. A community study of T lymphocyte subsets and malaria parasitaemia. Trans R Soc Trop Med Hyg 88:709-710. http://dx.doi.org/10.1016/0035-9203(94)90242-9.
36. Hviid L, Kurtzhals JA, Goka BQ, Oliver-Commey JO, Nkrumah FK, Theander TG. 1997. Rapid reemergence of T cells into peripheral circulation following treatment of severe and uncomplicated Plasmodium falciparum malaria. Infect Immun 65:4090-4093.
37. Hviid L, Theander TG, Abdulhadi NH, Abu-Zeid YA, Bayoumi RA, Jensen JB. 1991. Transient depletion of T cells with high LFA-1 expression from peripheral circulation during acute Plasmodium falciparum malaria. Eur J Immunol 21:1249-1253. http://dx.doi.org/10.1002/eji.1830210523.
38. Langhorne J, Simon-Haarhaus B. 1991. Differential T cell responses to Plasmodium chabaudi chabaudi in peripheral blood and spleens of C57BL/6 mice during infection. J Immunol 146:2771-2775.
39. Vukmanovic-Stejic M, Agius E, Booth N, Dunne PJ, Lacy KE, Reed JR, Sobande TO, Kissane S, Salmon M, Rustin MH, Akbar AN. 2008. The kinetics of CD4+Foxp3+T cell accumulation during a human cutaneous antigen-specific memory response in vivo. J Clin Invest 118:3639-3650. http://dx.doi.org/10.1172/JCI35834.
40. Torres KJ, Villasis E, Bendezu J, Chauca J, Vinetz JM, Gamboa D. 2014. Relationship of regulatory T cells to Plasmodium falciparum malaria symptomatology in a hypoendemic region. Malar J 13:108. http://dx.doi.org/10.1186/1475-2875-13-108.
41. Wammes LJ, Wiria AE, Toenhake CG, Hamid F, Liu KY, Suryani H, Kaisar MM, Verweij JJ, Sartono E, Supali T, Smits HH, Luty AJ, Yazdanbakhsh M. 2013. Asymptomatic plasmodial infection is associated with increased tumor necrosis factor receptor II-expressing regulatory T cells and suppressed type 2 immune responses. J Infect Dis 207:1590-1599. http://dx.doi.org/10.1093/infdis/jit058.
42. Berretta F, St-Pierre J, Piccirillo CA, Stevenson MM. 2011. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of bloodstage malaria infection. J Immunol 186:4862-4871. http://dx.doi.org/10.4049/jimmunol.1003777.
43. Abel S, Luckheide N, Westendorf AM, Geffers R, Roers A, Muller W, Sparwasser T, Matuschewski K, Buer J, Hansen W. 2012. Strong impact of CD4+ Foxp3+ regulatory T cells and limited effect of T cell-derived IL-10 on pathogen clearance during Plasmodium yoelii infection. J Immunol 188:5467-5477. http://dx.doi.org/10.4049/jimmunol.1102223.
44. Wijayalath W, Danner R, Kleschenko Y, Majji S, Villasante EF, Richie TL, Brumeanu TD, David CS, Casares S. 2014. HLA class II (DR0401) molecules induce Foxp3+ regulatory T cell suppression of B cells in Plasmodium yoelii strain 17XNL malaria. Infect Immun 82:286-297. http://dx.doi.org/10.1128/IAI.00272-13.
45. Gandhi R, Anderson DE, Weiner HL. 2007. Cutting edge: immature human dendritic cells express latency-associated peptide and inhibit T cell activation in a TGF-beta-dependent manner. J Immunol 178:4017-4021. http://dx.doi.org/10.4049/jimmunol.178.7.4017.
46. Urban BC, Cordery D, Shafi MJ, Bull PC, Newbold CI, Williams TN, Marsh K. 2006. The frequency of BDCA3-positive dendritic cells is increased in the peripheral circulation of Kenyan children with severe malaria. Infect Immun 74:6700 - 6706. http://dx.doi.org/10.1128/IAI.00861-06.
47. Bottius E, Guanzirolli A, Trape JF, Rogier C, Konate L, Druilhe P. 1996. Malaria: even more chronic in nature than previously thought; evidence for subpatent parasitaemia detectable by the polymerase chain reaction. Trans R Soc Trop Med Hyg 90:15-19. http://dx.doi.org/10.1016/S0035-9203(96)90463-0.
48. Coura JR, Suarez-Mutis M, Ladeia-Andrade S. 2006. A new challenge for malaria control in Brazil: asymptomatic Plasmodium infection-a review. Mem Inst Oswaldo Cruz 101:229-237.
49. Cunnington AJ, Riley EM. 2010. Suppression of vaccine responses by malaria: insignificant or overlooked? Expert Rev Vaccines 9:409-429. http://dx.doi.org/10.1586/erv.10.16.